Mehow Innovative Cash Ratio
Cash Ratio of Mehow Innovative (301363.SZ) as of Nov 5, 2026.
Get this data via API
Financial Data API
Cash Ratio
0.00
Last updated:
Cash Ratio of Mehow Innovative is 2025 0.00 . Cash Ratio of Mehow Innovative was 2024 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Mehow Innovative Stock analysis
What does Mehow Innovative do? Mehow Innovative Ltd. generates revenue through the design, development, manufacturing, and services of medical equipment. The company offers full-process services from product design and development to mass production and delivery for domestic and foreign medical device customers. Its main products include home ventilator components, precision molds and automation equipment, cochlear implant components, and spirometers. These components are primarily used in the production of household ventilators and cochlear implant products. The firm distributes its products in both domestic and overseas markets, serving medical device manufacturers and healthcare providers who require specialized equipment and components for their production processes.
Mehow Innovative Ltd. focuses on providing comprehensive solutions for medical device manufacturers, including home ventilator components and cochlear implant components. The company's precision molds and automation equipment support the manufacturing of various medical devices, while spirometers are offered as standalone medical device products. Domestic and overseas markets represent key segments for the company's product distribution, with a particular emphasis on serving clients involved in the production of ventilators and cochlear implants. The firm's services extend from initial design to final delivery, ensuring end-to-end support for its customers' medical device needs.
The company's revenue streams are derived from the sale of home ventilator components, precision molds, automation equipment, cochlear implant components, and spirometers. These products cater to the needs of medical device manufacturers who require specialized components for household ventilators and cochlear implant systems. By offering full-process services, Mehow Innovative Ltd. positions itself as a key supplier in the medical equipment sector, serving both domestic and international clients across multiple market segments. Mehow Innovative is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Mehow Innovative stock
On Eulerpool you can find the complete historical development of Cash Ratio Mehow Innovative since 2006 – with annual values, charts, and detailed analysis.
The Cash Ratio is the most conservative liquidity metric, comparing only cash and equivalents to current liabilities.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Ratio's Mehow Innovative with sector peers and the industry average to assess whether it is attractive.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Leverage — Mehow Innovative
All Key Metrics — Mehow Innovative
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth